References
- Understanding Glaucoma. London: The Royal College of Ophthalmologists/International Glaucoma Association, PNIB, 2000.
- Evans J, Rooney C, Ashwood F et al. Blindness and partial sight in England and Wales, April 1990 – March 1991 Health Trends 1996; 28: 5–12.
- Quigley HA. Number of patients with glaucoma worldwide. British Journal of Ophthalmology 1996; 80: 389–393.
- Coyle D, Drummond M. The economic burden of glaucoma in the UK. The need for a far-sighted policy. Pharmacoeconomics 1995; 7: 484–489.
- Kobelt G, Jonsson L, Gerdtham U et al. Direct costs of glaucoma management following initiation of medical therapy.
- Jönsson B, Krieglstein G. Primary open- angle glaucoma-differences in international treatment patterns and costs. Oxford, Isis Medical Media Ltd; 1998
- Kooner KS, Zimmerman TJ. The cost of antiglaucoma medications. Annals of Ophthalmology 1987; 19: 327–328.
- Recent development in primary open angle glaucoma and ocular hypertensions. The National Prescribing Centre MeReC Bulletin 2003; 13: 17.
- Schwartz GF, Platt R. Measuring persistency and intraocular pressure- controlled days in patients receiving topical glaucoma medications. American Journal of Managed Care 2002; 8 (Suppl.): S278-280.
- Rouland JF, Le Pen C, Gouveia Pinto C et al. Cost-minimisation study of dorzolamide versus brinzolamide in the treatment of ocular hypertension and primary open-angle glaucoma: in four European countries. Pharmacoeconomics 2003; 21: 201–213.
- Halpern MT, Sorensen S, Covert D et al. Longitudinal glaucoma treatment patterns with brinzolamide versus dorzolamide. Journal of Medical Economics 2000; 3: 111–120.
- http://www.gprd.com/
- http://www.bnf.org/
- Barnebey H, Kwok SY. Patients’ acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting. Clinical Therapeutics 2000; 22: 1204–1212.
- Seong GJ, Lee SC, Lee JH et al. Comparisons of intraocular-pressure- lowering efficacy and side effects of 2% dorzolamide and 1% brinzolamide. Ophthalmologica 2001; 215: 188–191.
- Anderson DR. The management of elevated intraocular pressure with normal optic discs and visual fields. Surveys of Ophthalmology, 1977; 21: 479–489
- Reyes E, Izquierdo NJ, Blasini M. Adverse drugs reactions associated with glaucoma medications. Boletin de la Asociacion Medica de Puerto Rico 1997; 89: 51–55.